IT Orange | IT桔子

Shennandian A intends to acquire about 55% stake in Unilever

Unilever is a one-stop supply chain management service company. Unilever is committed to the research and innovation of financial supply chain technology, logistics technology, risk control technology and information technology, and provides business flow, logistics, capital flow, information flow, Workflow as one of the supply chain outsourcing solutions and operations. Recently, Shennandian A intends to […]

Shennandian A intends to acquire about 55% stake in Unilever Read More »

Digital Twin Model Technology completes tens of millions of Pre-A round of financing

Digital Twin Model Technology is a modeling and governance cloud platform developer. It is committed to providing Chinese enterprises with the implementation methodology and supporting tool system of digital overall design and continuous governance mechanism through a new generation of enterprise architecture governance platform. Mainly master the core technology of organizational modeling, and launch EMAGE,

Digital Twin Model Technology completes tens of millions of Pre-A round of financing Read More »

Tianyi Shangjia plans to acquire 90% equity of Jingyiyang for 270 million yuan

Jingyiyang is a manufacturer of monocrystalline silicon rods and wafers. It mainly provides supporting products for the production of solar-grade monocrystalline silicon rods and wafers and auxiliary materials – photovoltaic quartz crucibles. Recently, Tianyi Shangjia announced that it plans to use 270 million yuan of its own or self-raised funds to acquire 90% of the

Tianyi Shangjia plans to acquire 90% equity of Jingyiyang for 270 million yuan Read More »

Several executives of self-driving company “Pony.ai” leave

Pony.ai, the leading autonomous driving company, is currently undergoing business adjustments, and the company is also experiencing high-level personnel turmoil: Kevin, the head of the infrastructure and data department at the California R&D center, has previously left. In addition, the adjustment also involves the map department, and Feng Yi, the map director who is also

Several executives of self-driving company “Pony.ai” leave Read More »

Guanzhishan Mineral Water has obtained strategic investment, and Panpan Food has invested

Guanzhishan Mineral Water is a wholesale and retailer of mineral water production. It has domestic advanced mineral water mining, production, and canning equipment. It has independent mining, production, packaging, and transportation capabilities. , The filling and capping process is aseptic, automated and intelligent, which eliminates the possible pollution caused by manual operation in the water

Guanzhishan Mineral Water has obtained strategic investment, and Panpan Food has invested Read More »

Yibin Paper completes a new round of financing of RMB 509 million

Yibin Paper is a manufacturer of paper products. The company mainly produces paper cup base paper, newsprint, cultural paper, chemical fiber pulp, offset paper, commercial wood pulp, box board paper, tea board paper, copy paper, toilet paper, etc. Users provide paper packaging bag booking service. Recently, 509 million yuan of private placement financing was completed

Yibin Paper completes a new round of financing of RMB 509 million Read More »

AI Proteins raises $18.2 million in seed funding

AI Proteins is a protein therapy developer capable of developing inexpensive, durable, highly specific proteins. AI Proteins is reimagining protein therapy with a fresh approach to designing entirely new proteins. Using AI-based design and a high-throughput drug discovery platform, AI Proteins creates de novo proteins optimized for specific therapeutic applications. AI Proteins announced the completion

AI Proteins raises $18.2 million in seed funding Read More »

Hairong Pharma plans to raise an additional 56 million yuan

Hairong Pharma is a technology-based enterprise focusing on the rapid development of the biopharmaceutical field, a strategic emerging industry. In the short term, the company will adhere to the R&D and industrialization of innovative drugs and the first domestic generic drugs, and adopt a win-win model such as partial equity transfer, sales commission, and market

Hairong Pharma plans to raise an additional 56 million yuan Read More »